Fardella C - Search Results

1

Angiotensin I-converting enzyme insertion/deletion polymorphism and adrenergic response to exercise in hypertensive patients.

Jalil JE, Córdova S, Ocaranza Ma, Schumacher E, Braun S, Chamorro G, Fardella C, Lavandero S. Jalil JE, et al. Among authors: fardella c. Med Sci Monit. 2002 Aug;8(8):CR566-71. Med Sci Monit. 2002. PMID: 12165743

2

Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.

Fardella CE, Pinto M, Mosso L, Gómez-Sánchez C, Jalil J, Montero J. Fardella CE, et al. J Clin Endocrinol Metab. 2001 Oct;86(10):4805-7. doi: 10.1210/jcem.86.10.7920. J Clin Endocrinol Metab. 2001. PMID: 11600544

3

Neutral endopeptidase and angiotensin I converting enzyme insertion/deletion gene polymorphism in humans.

Jalil JE, Ocaranza MP, Oliveri C, Córdova S, Godoy I, Chamorro G, Braun S, Fardella C, Michel JB, Lavandero S. Jalil JE, et al. Among authors: fardella c. J Hum Hypertens. 2004 Feb;18(2):119-25. doi: 10.1038/sj.jhh.1001646. J Hum Hypertens. 2004. PMID: 14730327

4

Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients.

Stehr CB, Mellado R, Ocaranza MP, Carvajal CA, Mosso L, Becerra E, Solis M, García L, Lavandero S, Jalil J, Fardella CE. Stehr CB, et al. J Hypertens. 2010 Oct;28(10):2120-6. doi: 10.1097/HJH.0b013e32833d0177. J Hypertens. 2010. PMID: 20683341

5

Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure.

Rodríguez-Portales JA, Fardella C. Rodríguez-Portales JA, et al. Among authors: fardella c. J Endocrinol Invest. 1994 May;17(5):307-11. doi: 10.1007/BF03348986. J Endocrinol Invest. 1994. PMID: 8077614

6

[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].

Mosso L, Fardella C, Montero J, Rojas P, Sánchez O, Rojas V, Rojas A, Huete A, Soto J, Foradori A. Mosso L, et al. Among authors: fardella c. Rev Med Chil. 1999 Jul;127(7):800-6. Rev Med Chil. 1999. PMID: 10668287 Spanish.

7

Primary aldosteronism and hypertensive disease.

Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE. Mosso L, et al. Among authors: fardella ce. Hypertension. 2003 Aug;42(2):161-5. doi: 10.1161/01.HYP.0000079505.25750.11. Epub 2003 Jun 9. Hypertension. 2003. PMID: 12796282

8

Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.

Carvajal CA, Romero DG, Mosso LM, González AA, Campino C, Montero J, Fardella CE. Carvajal CA, et al. Among authors: fardella ce. J Hypertens. 2005 Jan;23(1):71-7. doi: 10.1097/00004872-200501000-00015. J Hypertens. 2005. PMID: 15643127

9

[Microsatellite marker AGAT of the mineralocorticoid receptor gene is associated with plasma renin activity in patients with essential hypertension].

Muñoz-Brauning CR, Carvajal CA, Mosso LM, Valdivia G, Fardella CE. Muñoz-Brauning CR, et al. Rev Med Chil. 2005 Dec;133(12):1415-23. doi: 10.4067/s0034-98872005001200002. Epub 2006 Jan 27. Rev Med Chil. 2005. PMID: 16446868 Free article. Spanish.

10

A polymorphic GT short tandem repeat affecting beta-ENaC mRNA expression is associated with low renin essential hypertension.

González AA, Carvajal CA, Riquelme E, Krall PM, Munoz CR, Mosso LM, Kalergis AM, Fardella CE. González AA, et al. Am J Hypertens. 2007 Jul;20(7):800-6. doi: 10.1016/j.amjhyper.2007.02.019. Am J Hypertens. 2007. PMID: 17586416

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters